PRTN3 and rheumatoid arthritis: The differential expression of these 6 miRNAs in serum distinguishes RA patients and ACPA-positive at-risk individuals afflicted with arthralgia from healthy subjects.237 In addition, circulating miR-103a-3p has been identified as a robust biomarker that can be used to identify populations at risk of imminent RA for timely intervention.